Frits van Rhee, M.D., Ph.D. Hematologist/Oncologist
Primary Appointment Location
4018 W. Capitol Ave.
Winthrop P. Rockefeller Cancer Institute
Little Rock, AR 72205
- Appointment Phone Number
- (501) 686-7105
New and Returning Patients
- Provides Second Opinion
- Patient Type
About Dr. van Rhee
Frits van Rhee, M.D., Ph.D., is a Professor of Medicine and Clinical Director of the UAMS Myeloma Center. He earned his medical degree from Erasmus University, Rotterdam, Netherlands, and his Ph.D. at the Imperial College of Science, Medicine and Technology, University of London. Dr. van Rhee trained in Internal Medicine and Hematology in the U.K., and in Bone Marrow Transplantation at John Radcliffe University Hospital in Oxford and the Royal Postgraduate Medical School in London. He holds the Charles and Clydene Scharlau Chair for Hematological Malignancies.
Dr. van Rhee is an international expert on Castleman Disease, with one of the largest populations of Castleman Disease patients in the world. He also is an expert in multiple myeloma and other hematologic malignancies, with a research focus in immunotherapy.
Dr. van Rhee is a member of the International Society for Cellular Therapy, the International Society for Experimental Hematology, the European Group for Bone and Marrow Transplantation, the Royal college of Physicians (U.K.), the Royal College of Pathologists (U.K.), and the American Society of Hematology. He has U.K. board certification in Internal Medicine and Hematology.
Dr. van Rhee's Academic Background
- Internal Medicine
- John Radcliffe University Hospital
Bone Marrow Transplantation
- Hammersmith Hospital
- University Hospital
- Graduate School
- University of London
Doctor of Philosophy
- Medical School
- Erasmus University Rotterdam
- American Board of Internal Medicine
- MRCPath Hematology
UAMS providers care for a broad range of conditions, some of which may not be listed below.
Dr. van Rhee's Areas of Expertise
The Winthrop P. Rockefeller Cancer Institute at UAMS is Arkansas’ most comprehensive cancer treatment and research facility.
Myeloma Care (Part of Cancer Care)
Myeloma and other plasma cell neoplasms are diseases in which the body produces too many plasma cells in the bone marrow, and these cells become abnormal.